RVP-001

RVP-001 manganese-based MRI contrast agent · Reveal Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RVP-001, covering 2023-10-23 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent [Phase 2]